Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1941478

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1941478

Biosensors Market Size, Share & Trends Analysis Report By Technology (Electrochemical, Thermal, Piezoelectric), By Application (Medical, Bioreactor, Agriculture), By End Use (PoC Testing, Food Industry), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Biosensors Market Summary

The global biosensors market size was estimated at USD 32.21 billion in 2025 and is projected to reach USD 63.96 billion by 2033, growing at a CAGR of 9.12% from 2026 to 2033. The demand for biosensors is increasing due to the diversity of medical applications, growing prevalence of chronic and non-communicable diseases such as diabetes and hypertension, high demand for compact diagnostic devices, and rapid technological advancements.

The increasing demand for health monitoring and fitness tracking, coupled with rising interest in personalized digital wellness, is a primary driver in the growth of the market. In addition, nanotechnology-based biosensors are expected to have wide application scope in various industries, such as food analysis, imaging, and microbial activity monitoring. The global market is consolidating due to the growing preference for non-invasive wearable biosensors, rising popularity of medical devices & specialty drugs, and increasing research collaborations between various manufacturers.

Moreover, biosensors enable continuous, real-time monitoring of physiological metrics such as heart rate, sleep patterns, blood oxygen saturation, and steps taken, providing actionable data for consumers and healthcare professionals. For instance, according to an article published by the University of Arizona Health Sciences in June 2025, advanced sensor platforms use deep learning models to predict physiological events, including labor onset and stress response, from high-frequency biometric data. These devices serve as an early warning system to detect health risks prior to symptom onset. This approach transforms health management from episodic to proactive intervention, reducing the burden of late diagnoses and emergency care.

Similarly, the Cardiosense CardioTag is a significant example of this trend. It is an FDA-cleared, multimodal wearable sensor for cardiac monitoring, combining ECG (electrocardiogram), PPG (photoplethysmogram), and SCG (seismocardiogram) signals. It leverages advanced AI algorithms to analyze these high-fidelity signals for early heart failure detection, comprehensive cardiac assessment, and personalized therapy guidance, enabling noninvasive measurement of cardiac mechanics, hemodynamics (such as left ventricular ejection time), and volume status in both clinical and home settings.

Furthermore, advances in artificial intelligence, machine learning, and sensor miniaturization have significantly enhanced the functionality and accuracy of wearable devices. Integration of AI algorithms enables real-time data processing, predictive analytics, and personalized feedback. In patient management, Medtronic's edge AI-enabled insulin delivery systems demonstrate clinical-grade, real-time decision-making by fusing biosensor streams for dynamic insulin dose adjustment. This system highlights the capability of AI-enabled wearables to deliver responsive, personalized interventions without requiring external connectivity, thereby supporting precision medicine in ambulatory settings. In addition, smart rings are gaining traction due to improved measurement accuracy from finger-based sensors and enhanced comfort for 24-hour wear.

Furthermore, increasing partnerships and collaborations withing the industry contribute to market growth. For instance, partnerships between French firms and global startups, such as Livingston's collaboration for biosensors and wearables in June 2025, enable scalable production and global market reach. This expansion supports personalized fitness, wellness, and lifestyle applications, reflecting increasing adoption among fitness enthusiasts and urban consumers.

"The diagnostics industry has changed post COVID, wearable technology has risen up the agenda, along with AI having an increasing impact, and we think the collaboration with Linxens will keep us ahead of the curve while significantly improving our market reach."

Kevin Fallon, FlexMedical's CEO and co-founder,

"This collaboration expands our biosensor portfolio by integrating functionalisation capabilities, enabling us to deliver end-to-end solutions - from flex-PCB or printed electrodes to fully functional sensor platforms. Together, we streamline the journey from R&D to mass production, accelerating the delivery of innovative diagnostic solutions."

Minh Le, vice-president of Linxens Healthcare

Global Biosensors Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biosensors market report based on technology, application, end use, and region.

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Thermal
  • Electrochemical
  • Piezoelectric
  • Optical
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical
    • Cholesterol
    • Blood Glucose
    • Blood gas analyzer
    • Pregnancy testing
    • Drug discovery
    • Infectious disease
  • Food Toxicity
  • Bioreactor
  • Agriculture
  • Environment
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Home Healthcare Diagnostics
  • PoC Testing
  • Food Industry
  • Research Laboratories
  • Security and Bio-defense
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Product Code: 978-1-68038-321-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Biosensors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Biosensors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. Biosensors Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Biosensors Market Application Movement Analysis
  • 4.3. Global Biosensors Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Medical
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Cholesterol
      • 4.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Blood Glucose
      • 4.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.4. Blood Gas Analyzer
      • 4.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.5. Pregnancy Testing
      • 4.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.6. Drug Discovery
      • 4.4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.7. Infectious Disease
      • 4.4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Food Toxicity
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Bioreactor
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Agriculture
    • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Environment
    • 4.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Biosensors Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Biosensors Market Technology Movement Analysis
  • 5.3. Global Biosensors Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Thermal
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Electrochemical
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Piezoelectric
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Optical
    • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Biosensors Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Biosensors Market End Use Movement Analysis
  • 6.3. Global Biosensors Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Home Healthcare Diagnostics
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. PoC Testing
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Food Industry
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Research Laboratories
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Security and Bio-defense
    • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Biosensors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Abbott Laboratories
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medtronic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Biosensors International Group
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Pinnacle Technology, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Dupont.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Sensirion AG
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Thermo Fisher Scientific, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. F. Hoffmann-La Roche AG
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Siemens Healthineers
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Zimmer & Peacock AS
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Metrohm AG
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. DexCom, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Universal Biosensors, Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Johnson & Johnson Services, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Nix Biosensors
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Cyrcadia Health
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Lifescan
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
Product Code: 978-1-68038-321-8

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global biosensors market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 4 Global biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 8 North America biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 11 U.S. biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 15 Canada biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 17 Mexico biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 21 Europe biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Europe biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 27 Germany biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Germany biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 30 France biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 31 France biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 33 Italy biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Italy biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 36 Spain biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Spain biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 39 Denmark biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 42 Sweden biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 45 Norway biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Norway biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 52 China biosensors market, by modality, 2021 - 2033 (USD Million)
  • Table 53 China biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 54 China biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Japan biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Japan biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 59 India biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 60 India biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 61 South Korea biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 63 South Korea biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Australia biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 66 Australia biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Thailand biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 69 Thailand biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Latin America biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Latin America biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Brazil biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 76 Brazil biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Argentina biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 79 Argentina biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 80 MEA biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 81 MEA biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 83 MEA biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 84 South Africa biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 86 South Africa biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 90 UAE biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 92 UAE biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 95 Kuwait biosensors market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 Biosensors market: Market outlook
  • Fig. 6 Biosensors market: Segment outlook
  • Fig. 7 Biosensors market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 Biosensors market driver impact
  • Fig. 10 Biosensors market restraint impact
  • Fig. 11 Biosensors market: Technology outlook and key takeaways
  • Fig. 12 Biosensors market: Technology movement analysis
  • Fig. 13 Thermal market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Electrochemical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Piezoelectric market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Optical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Biosensors market: Application outlook and key takeaways
  • Fig. 18 Biosensors market: Application movement analysis
  • Fig. 19 Medical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Cholesterol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Blood glucose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Blood gas analyzer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Pregnancy testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Infectious disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Food toxicity market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Bioreactor market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Agriculture market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Environment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Biosensors market: End use outlook and key takeaways
  • Fig. 32 Biosensors market: End use movement analysis
  • Fig. 33 Home healthcare diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 PoC testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Food industry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Research laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Security and bio-defense market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Global biosensors market: Regional outlook and key takeaways
  • Fig. 39 Global biosensors market: Regional movement analysis
  • Fig. 40 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. key country dynamics
  • Fig. 42 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Mexico key country dynamics
  • Fig. 46 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Germany key country dynamics
  • Fig. 51 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 France key country dynamics
  • Fig. 53 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Italy key country dynamics
  • Fig. 55 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Spain key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Denmark key country dynamics
  • Fig. 59 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Sweden key country dynamics
  • Fig. 61 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Norway key country dynamics
  • Fig. 63 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Japan key country dynamics
  • Fig. 66 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 China key country dynamics
  • Fig. 68 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 India key country dynamics
  • Fig. 70 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Thailand key country dynamics
  • Fig. 72 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 South Korea key country dynamics
  • Fig. 74 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Australia key country dynamics
  • Fig. 76 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Argentina key country dynamics
  • Fig. 81 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 South Africa key country dynamics
  • Fig. 84 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamics
  • Fig. 86 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 UAE key country dynamics
  • Fig. 88 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Kuwait key country dynamics
  • Fig. 90 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!